These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 15386810)
1. Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry. Danchin N; Charpentier G; Ledru F; Vaur L; Guéret P; Hanania G; Blanchard D; Lablanche JM; Genès N; Cambou JP Diabetes Metab Res Rev; 2005; 21(2):143-9. PubMed ID: 15386810 [TBL] [Abstract][Full Text] [Related]
2. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA). Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA; Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601 [TBL] [Abstract][Full Text] [Related]
3. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Danchin N; Blanchard D; Steg PG; Sauval P; Hanania G; Goldstein P; Cambou JP; Guéret P; Vaur L; Boutalbi Y; Genès N; Lablanche JM; Circulation; 2004 Oct; 110(14):1909-15. PubMed ID: 15451803 [TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and outcome of diabetic patients with acute myocardial infarction. Data from the BLITZ-1 study. Casella G; Savonitto S; Chiarella F; Gonzini L; Di Chiara A; Bolognese L; De Servi S; Greco C; Zonzin P; Coccolini S; Maggioni AP; Boccanelli A; Ital Heart J; 2005 May; 6(5):374-83. PubMed ID: 15934409 [TBL] [Abstract][Full Text] [Related]
5. Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction. Zeller M; Danchin N; Simon D; Vahanian A; Lorgis L; Cottin Y; Berland J; Gueret P; Wyart P; Deturck R; Tabone X; Machecourt J; Leclercq F; Drouet E; Mulak G; Bataille V; Cambou JP; Ferrieres J; Simon T; J Clin Endocrinol Metab; 2010 Nov; 95(11):4993-5002. PubMed ID: 20702526 [TBL] [Abstract][Full Text] [Related]
6. Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide). Klamann A; Sarfert P; Launhardt V; Schulte G; Schmiegel WH; Nauck MA Eur Heart J; 2000 Feb; 21(3):220-9. PubMed ID: 10639304 [TBL] [Abstract][Full Text] [Related]
7. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study. De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F; J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968 [TBL] [Abstract][Full Text] [Related]
8. Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study. Horsdal HT; Johnsen SP; Søndergaard F; Jacobsen J; Thomsen RW; Schmitz O; Sørensen HT; Rungby J Diabetes Metab Res Rev; 2009 Sep; 25(6):515-22. PubMed ID: 19459168 [TBL] [Abstract][Full Text] [Related]
9. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group. Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799 [TBL] [Abstract][Full Text] [Related]
10. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics. Cambou JP; Simon T; Mulak G; Bataille V; Danchin N Arch Mal Coeur Vaiss; 2007; 100(6-7):524-34. PubMed ID: 17893635 [TBL] [Abstract][Full Text] [Related]
11. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T; Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434 [TBL] [Abstract][Full Text] [Related]
12. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin. Tentolouris N; Matsagura M; Psallas M; Chatzizacharias A; Fotia M; Arvanitis M; Katsilambros N Exp Clin Endocrinol Diabetes; 2005 May; 113(5):298-301. PubMed ID: 15926117 [TBL] [Abstract][Full Text] [Related]
13. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database. Milcent C; Dormont B; Durand-Zaleski I; Steg PG Circulation; 2007 Feb; 115(7):833-9. PubMed ID: 17309933 [TBL] [Abstract][Full Text] [Related]
14. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction. Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952 [TBL] [Abstract][Full Text] [Related]
15. Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Norhammar A; Stenestrand U; Lindbäck J; Wallentin L; Heart; 2008 Dec; 94(12):1565-70. PubMed ID: 18450842 [TBL] [Abstract][Full Text] [Related]
17. Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications. Colivicchi F; Mettimano M; Genovesi-Ebert A; Schinzari F; Iantorno M; Melina G; Santini M; Cardillo C; Melina D J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):267-72. PubMed ID: 18301144 [TBL] [Abstract][Full Text] [Related]
18. The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries. Svensson AM; Dellborg M; Abrahamsson P; Karlsson T; Herlitz J; Duval SJ; Berger AK; Luepker RV Int J Cardiol; 2007 Jul; 119(3):319-25. PubMed ID: 17067706 [TBL] [Abstract][Full Text] [Related]
20. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]